<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02626741</url>
  </required_header>
  <id_info>
    <org_study_id>647-2557-EC4</org_study_id>
    <nct_id>NCT02626741</nct_id>
  </id_info>
  <brief_title>Effect of a Meal Replacement on Weight Loss Obesity Patients With Metabolic Syndrome</brief_title>
  <acronym>SlimWell</acronym>
  <official_title>Effect of a Meal Replacement on Weight Loss Obesity Patients With Metabolic Syndrome : A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether meal replacement, SlimWell Â®, is effective
      in the treatment of obesity patients with metabolic syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The participants are divided into two groups: intervention group and control group. In the
      intervention group, the participants receive a meal replacement plus life style modification.
      In the control group, the participants receive only life style modification.

      Sample size calculation is 69 participants per group. Primary outcome is to compare the
      weight loss between the intervention group and control group.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participants with weight loss unit in kilograms</measure>
    <time_frame>3 months</time_frame>
    <description>Change from baseline body weight at 3 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participants with waist circumference change in centimeters</measure>
    <time_frame>3 months</time_frame>
    <description>Change from baseline waist circumference at 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants with triglyceride change in mg/dl.</measure>
    <time_frame>3 months</time_frame>
    <description>Change from baseline triglyceride at 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Grade 3 Through Grade 5 Adverse Events That Are Related to Study meal replacement, Graded According to NCI CTCAE Version 3.0</measure>
    <time_frame>3 months</time_frame>
    <description>Number of Patients With Grade 3 Through Grade 5 Adverse Events That Are Related to Study meal replacement, Graded According to NCI CTCAE Version 3.0 focus on Gastrointestinal side effects.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Abdominal Obesity-Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>meal replacement group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the participants receive a meal replacement plus life style modification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the participants receive life style modification only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>meal replacement group</intervention_name>
    <description>The participants will receive SlimWell 60 grams per meal for 2 meals per day plus life style modification including educational sessions of exercise, dietary intake, food record. The duration is 3 months.</description>
    <arm_group_label>meal replacement group</arm_group_label>
    <other_name>SlimWell</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>control group</intervention_name>
    <description>The participants will receive only life style modification including educational sessions of exercise, dietary intake, food record. The duration is 3 months.</description>
    <arm_group_label>meal replacement group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <other_name>only life style modification</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index more than or equal to 25 kg/m2

          -  Patients with metabolic syndrome

          -  Patients who are on anti-hypertensive drugs, oral hypoglycemic drugs and lipid
             lowering drugs.

        Exclusion Criteria:

          -  Uncontrolled diabetes patients

          -  Patients with gastrointestinal abnormalities

          -  Patients with cardiovascular diseases

          -  Patients with hematologic disorders

          -  Patients with Glomerular filtration rate less than 60 ml/min/1.73m2

          -  Patients with drug or alcohol abuse

          -  Pregnancy and lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kusuma Chaiyasoot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kusuma Chaiyasoot, MD</last_name>
    <phone>+66819304743</phone>
    <email>kusuma.chs@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Preyanuj Yamwong, MD</last_name>
    <phone>+66897750773</phone>
    <email>preyanuj.yam@mahidol.ac.th</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kusuma Chaiyasoot, MD</last_name>
      <phone>+66819304743</phone>
      <email>kusuma.chs@mahidol.ac.th</email>
    </contact>
    <investigator>
      <last_name>Kusuma Chaiyasoot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Leader NJ, Ryan L, Molyneaux L, Yue DK. How best to use partial meal replacement in managing overweight or obese patients with poorly controlled type 2 diabetes. Obesity (Silver Spring). 2013 Feb;21(2):251-3. doi: 10.1002/oby.20057.</citation>
    <PMID>23404963</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2015</study_first_submitted>
  <study_first_submitted_qc>December 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2015</study_first_posted>
  <last_update_submitted>December 8, 2015</last_update_submitted>
  <last_update_submitted_qc>December 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Obesity, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

